𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Anti-tumor immunity in b-lymphocyte-deprived mice. iii. immunity to primary moloney sarcoma virus-induced tumors

✍ Scribed by Julius Gordon; Howard T. Holden; Shraga Segal; Michael Feldman

Publisher
John Wiley and Sons
Year
1982
Tongue
French
Weight
1016 KB
Volume
29
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Tumor induction and immunity to tumors were studied following the injection of Moloney sarcoma virus (MSV) into mice whose B‐lymphocyte functions had been suppressed by the chronic administration of anti‐IgM antibodies. Two preparations of MSV were used; one which gives rise to tumors which uniformly regress in normal adult mice, and another which elicits progressively growing tumors in the majority of recipients. The tumor incidence, mean tumor size, and tempo of regression were not modified by treatment with anti‐IgM. However, whereas tumors induced by the regressor virus were all rejected in 19 NRG‐treated and 29 untreated recipients, continued growth was obtained in 2 of 23 B‐lymphocytedeprived mice. Furthermore, in 9 additional mice from this group, apparent rejection was followed by tumor recurrence at the site of the initial tumor. Continued growth was accompanied by widespread metastasis. These tumors were freely transplantable to normal syngeneic recipients. Metastasis and transplantability were also detected in 7 of 24 anti‐IgM‐treated mice given progressor virus, but were not seen in the control animals. Recurrence and metastasis was obtained despite the presence of high levels of specific cytotoxic T lymphocytes in the spleen. It is concluded that B lymphocytes or their products play an essential role in host protection against MSV‐induced tumors.

📜 SIMILAR VOLUMES

Cell-mediated immunity to Moloney sarcom
Cell-mediated immunity to Moloney sarcoma virus in mice. II. Analysis of antigenic specificities involved in T lymphocyte-mediated in vivo rejection of murine sarcoma virus-induced tumors
✍ R. M. Gorczynski; R. A. Knight 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 814 KB

## Abstract Sublethally irradiated BALB/c mice innoculated with Moloney sarcoma virus (MSV‐M) develop progressively growing tumors and die within 30 days of virus innoculation. These animals can be protected from tumor progression (and death) by innoculation of small numbers of MSV‐immune T lymphoc

The immune response to primary moloney s
The immune response to primary moloney sarcoma virus tumors in BALB/C mice: Cellular and humoral activity of long-term regressors
✍ E. W. Lamon; B. Andersson; H. Wigzell; E. M. Fenyö; E. Klein 📂 Article 📅 1974 🏛 John Wiley and Sons 🌐 French ⚖ 974 KB

## Abstract Adult BALB/c mice injected with Moloney sarcoma virus (MSV) developed local tumors at the site of inoculation which spontaneously regressed within 20–25 days after injection. Lymphocytes and sera from long‐term regressor animals were examined for their specific activities __in vitro__ a

Murine sarcoma virus (msv)-induced tumor
Murine sarcoma virus (msv)-induced tumors in mice. I. Distribution of msv-immune cytolytic t lymphocytes in vivo
✍ F. Plata; B. Sordat 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 French ⚖ 640 KB

## Abstract Quantitative studies using a ^51^Cr release assay were performed to analyse the time‐course of appearance and specificity of cytolytic cells in C57BI/6 mice inoculated with Moloney murine sarcoma virus (MSV). Various lymphoid organs were studied including spleen, mesenteric lymph nodes